Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spero Therapeutics (SPRO) Amortizatization of Intangibles (2018 - 2022)

Spero Therapeutics (SPRO) has disclosed Amortizatization of Intangibles for 5 consecutive years, with $10000.0 as the latest value for Q2 2022.

  • For the quarter ending Q2 2022, Amortizatization of Intangibles rose 116.67% year-over-year to $10000.0, compared with a TTM value of $10000.0 through Mar 2023, up 104.76%, and an annual FY2022 reading of -$13000.0, up 94.82% over the prior year.
  • Amortizatization of Intangibles was $10000.0 for Q2 2022 at Spero Therapeutics, up from -$23000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $355000.0 in Q1 2019 and bottomed at -$73000.0 in Q3 2021.
  • Average Amortizatization of Intangibles over 5 years is $66055.6, with a median of $27500.0 recorded in 2018.
  • The sharpest move saw Amortizatization of Intangibles soared 688.89% in 2019, then crashed 3550.0% in 2021.
  • Year by year, Amortizatization of Intangibles stood at $325000.0 in 2018, then crashed by 73.23% to $87000.0 in 2019, then crashed by 128.74% to -$25000.0 in 2020, then crashed by 116.0% to -$54000.0 in 2021, then surged by 118.52% to $10000.0 in 2022.
  • Business Quant data shows Amortizatization of Intangibles for SPRO at $10000.0 in Q2 2022, -$23000.0 in Q1 2022, and -$54000.0 in Q4 2021.